The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current ...
Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a ...
The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...